University of Twente develops technology for monitoring pain
NociTRACK prevents chronic pain
05 November 2009
Ten of thousands of patients suffer chronic pain as a result of operations, and this continues even after the wounds caused by the operation have healed. Researchers from the MIRA research institute – the University of Twente’s Research Institute for Biomedical Technology and Technical Medicine – have now developed a portable system that can be used to measure patients’ sensitivity to pain. The readings show which patients are likely to suffer chronic post-operative pain.
Some 10 to 25 per cent of all patients who undergo a minor
operation, such as for a hernia or breast enlargement, are
subsequently affected by chronic pain - in other words, tens of
thousands of people are forced to endure pain on a daily basis
after operations of this kind. In the case of more serious
operations, the proportion is as high as 30 to 50 per cent. Chronic
pain is defined as pain that can still be felt six months after an
operation; that is, after the wound caused by the operation has
healed.
It is still not entirely clear what causes chronic pain,
although it is known that hyperalgesia (heightened sensitivity to
pain) plays a key role. In cases where post-operative pain becomes
chronic, hyperalgesia spreads slowly from the area of the operation
to other parts of the body. If it is possible to establish whether
or not the increased sensitivity to pain will spread, it can be
determined more quickly whether or not the pain will become
chronic.
Scientists from the MIRA research institute at the University of
Twente have now devised a mobile system that can measure
sensitivity to pain simply and objectively. Thanks to their system,
it will soon be possible to measure the spread of hyperalgesia and
so discover whether or not pain will become chronic.
NociTRACK
The system designed by the Twente researchers, which they
have dubbed NociTRACK, consists of three parts: a device the size
of a large mobile phone, which measures pain sensitivity, a PDA for
collecting the data, and a central database that compares the data
from individual patients with previous measurements from the same
and other patients.
The device that takes the readings contains two electrodes,
which are placed onto the skin. As soon as the patient presses a
button on the device, it starts to emit weak electric pulses. These
gradually become stronger and stronger, and once the patient finds
the pain too uncomfortable, he lets go of the button and the pulses
stop. This is registered as the patient's pain threshold and by
comparing it to earlier readings, it is possible to determine
whether he has become more or less sensitive to pain, or whether
there has been any change at all.
There is also the option of using the system for measuring the
pain detection threshold, where the patient stops pressing the
button as soon as he starts to feel the pulses, and the pain
tolerance threshold, in which case he releases the button when the
pain is too great to bear.
With the help of larger localized facilities, the possibility of
conducting measurements of this kind already existed. However, what
makes NociTRACK unique is that a large number of patients can be
monitored at any time and in any location, not just in a single
examination room or with a fixed piece of equipment.
Applications
The NociTRACK system can be used for measuring pain
sensitivity objectively. The researchers believe it will reveal at
an earlier stage than is now the case whether the post-operative
pain being felt by any given patient will become chronic. In turn,
this means that any relevant therapy can be started much earlier.
Another feature of the system is that it can assess objectively how
effective pain medication is, something that will be useful in the
development of new medicines.
A patent for the system has now been applied for. As soon as it
has been granted, the system will be developed further, either in
an existing firm or a new spin-off company. The researchers are
currently in the process of forming a group of researchers and
clinicians who will be using the device.
Note for editors
The research has been performed at the MIRA research
institute and the Biomedical Signals and Systems (BSS) department
of the Faculty of Electrical Engineering, Mathematics and Computer
Science of the University of Twente. The project involves a close
collaboration between the researchers from the institute and
researchers from the Department of Anesthesiology of the UMC St
Radboud hospital in Nijmegen. The point of contact for the press is
Joost Bruysters,
telephone +31 (0)53 489 2773.